Company profile: Gallus BioPharma
1.1 - Company Overview
Company description
- Provider of contract manufacturing and development services for mammalian cell culture-derived biologics, supplying clinical and commercial bulk biologics to the biopharmaceutical industry in the United States and internationally, with capabilities in process and analytical development, process validation, cell banking, stability testing, QA/QC, regulatory support, and aseptic fill-finish (vial filling, inspection, labeling).
Products and services
- Aseptic Fill-Finish: Performs vial filling for parenteral pharmaceuticals, integrating inspection and labeling to maintain sterility and precise identification
- Contract Manufacturing: Produces mammalian cell culture-derived bulk biologics at clinical and commercial scale for the biopharmaceutical industry in the United States and internationally
- Process Development: Develops cell lines and optimizes upstream and downstream processes, including analytical method development for biologics
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Gallus BioPharma
Life Science Connect
HQ: United States
Website
- Description: Provider of life science content marketing and sales enablement services, offering the Templeton Customer Insights Platform for purchasing journey insights and content optimization; the Follow Your Buyer Methodology; custom newsletters; Enhanced Lead Intelligence (ELI) reports; and content services including creation and distribution via webinars.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Life Science Connect company profile →
Intrinsic Imaging
HQ: United States
Website
- Description: Provider of full-service medical imaging core lab solutions supporting Phase I-IV Clinical Trials and Class I-III Medical Device Trials. Services include study and site management across 4,000 imaging sites in 75 countries, optimized Imaging Charters, ISO-certified image acquisition protocols, and clinical trial imaging solutions for pharmaceutical, biotechnology, and medical device companies, including AI/CAD clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Intrinsic Imaging company profile →
Pyxant Labs
HQ: United States
Website
- Description: Provider of GLP bioanalytical chemistry services as a contract research laboratory for life sciences clients, offering bioanalytical method development (validation and optimization), analytical and bioanalytical support for ADME and PK/PD studies, and spatial bioanalysis and spatial biology solutions from discovery through clinical development and NDA approval.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pyxant Labs company profile →
Resilience
HQ: United States
Website
- Description: Provider of technology-driven biomanufacturing solutions expanding access to complex medicines and protecting biopharmaceutical supply chains, delivering cGMP manufacturing from pre-clinical through commercial stages and end-to-end platforms for cell and gene therapies, biologics, vaccines, and nucleic acids, with process development, analytical testing, supply chain management, and modular manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Resilience company profile →
ProPharma
HQ: United States
Website
- Description: Provider of independent, single-source regulatory, compliance, pharmacovigilance, and medical information services for pharmaceutical, biotechnology, and medical device companies; offering RCO custom solutions across the full product lifecycle, tailored MedTech solutions from concept to market, full-service Oncology CRO capabilities, global lifecycle solutions, and Prodigy technology to de-risk decision making and drive value.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProPharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Gallus BioPharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Gallus BioPharma
2.2 - Growth funds investing in similar companies to Gallus BioPharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Gallus BioPharma
4.2 - Public trading comparable groups for Gallus BioPharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →